Palisade Asset Management, LLC Q3 2022 vs. Q4 2022 Holdings: Which Stocks Made the Cut?
Ava Hoppe | 2 May, 2023
Investing in the stock market requires a keen eye for detail, and that’s exactly what Palisade Asset Management, LLC brought to the table. With the release of their Q3 2022 vs. Q4 2022 13F holdings comparison, investors can take a closer look at the stocks that made the cut, those that were trimmed, and what this means for the future.
Microsoft Corp Leads the Pack
Taking the top spot on Palisade Asset Management, LLC’s holdings comparison is Microsoft Corp. Although there was a slight decrease in the number of shares held, the value increased by 2.9% from Q3 to Q4. It appears as though Palisade is confident in Microsoft's performance and expects continued growth in the coming quarter.
Apple Inc Takes a Hit
In contrast to Microsoft, Apple Inc saw an increase in the number of shares held by Palisade, although their value took a slight hit. While some investors may see this as cause for concern, others may view this dip as an opportunity to buy Apple stock at a lower price and benefit from its eventual rebound.
UnitedHealth Group Inc Skyrockets
One of the most notable changes in Palisade Asset Management, LLC’s holdings is the skyrocketing value of UnitedHealth Group Inc. The number of shares held increased by over 50%, with the value surging by over 60%. This suggests that Palisade believes that the healthcare company is poised for a bright future.
Other Notable Changes
While several stocks remained relatively unchanged in Palisade’s holdings, there were a handful of notable changes. ASSOCIATED BANC CORP, for instance, was not held by Palisade in Q3 but had over 1 million shares in Q4. On the other hand, stocks like 3M Co and Baxter Intl Inc saw a decrease in both the number of shares held and their value.
The Takeaway
Overall, Palisade Asset Management, LLC’s Q3 2022 vs. Q4 2022 holdings comparison provides investors with valuable insights into the company’s strategy. With changes in holdings ranging from substantial gains to minor dips, it’s clear that Palisade is constantly evaluating its positions and making adjustments accordingly. As always, investors should closely examine their own investment goals and risk tolerance before following Palisade’s lead.
Other Posts
- Old Bellows Partners LP Q2 2018 vs. Q3 2018 13F Holdings Comparison: A Dive into the Fund's Recent Changes
- Navigating the Future: How Strategic Financing Elevates Tech in Niche Sectors
- Macroview Investment Management LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- A Look into Goodnow Investment Group's Q3 vs. Q4 2022 Holdings: Winners and Losers
- Bouchey Financial Group Ltd Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Whitehorse Liquidity Partners Expands Capital Management Team: Introducing Two Senior Hires
- Winch Advisory Services, LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- ETF Portfolio Partners, Inc. Q3 2023 vs. Q4 2023: A Comprehensive Analysis of Holdings
- Longview Partners 13F Holdings Comparison: Q3 2022 vs Q4 2022
- **Peloton Equity Leads Growth Investment in OnPoint Healthcare Partners**